Targeting growth factor and cytokine receptors with recombinant peptide libraries

Current Opinion in Chemical Biology

Volumn 2, Issue 3, 1998, Pages 328-334

  Dower, William J ^a  

^a AFFYMAX RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; GROWTH FACTOR RECEPTOR; INTERLEUKIN 1 RECEPTOR; PEPTIDE LIBRARY; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN CONFORMATION; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; CONSERVED SEQUENCE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PROTEIN CONFORMATION; RECEPTORS, CYTOKINE; RECEPTORS, GROWTH FACTOR; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS;

EID: 0032086337     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(98)80005-7     Document Type: Article

References (35)

1. Georgiou G, Stathopoulos C, Daugherty PS, Nayak AR, Iverson BL, Curtiss R III: Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines. Nat Biotechnol 1997, 15:29-34. A concise overview of a variety of systems for displaying protein and peptides on the surfaces of micro-organisms.
2. Lowman HB: Bacteriophage display and discovery of peptide leads for drug development. Annu Rev Biophys Biomol Struct 1997, 26:401-424. A very good review of recent developments in phage display technology.
3. Katz BA: Structural and mechanistic determinants of affinity and specificity of ligands discovered or engineered by phage display. Annu Rev Biophys Biomol Struct 1997, 26:27-45. An analysis of the principles of ligand selection by phage display.
4. Cwirla S, Peters E, Barrett R, Dower, W: Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci USA 1990, 87:6378-6382.
5. Scott J, Smith GP: Searching for peptide ligands with an epitope library. Science 1990, 249:386-390.
6. Greenwood J, Willis AE, Perham RN: Multiple display of foreign peptide on a filamentous bacteriophage. Peptides from plasmodium falciparum circumsporozoite protein as antigens. J Mol Biol 1991, 220:821-827.
7. Felici F, Castagnoli L, Musacchio A, Jappelli R, Cesareni G: Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J Mol Biol 1991, 222:301-310.
8. Cull MG, Miller JF, Schatz, RJ: Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor. Proc Natl Acad Sci USA 1992, 89:1865-1869.
9. Gates CM, Stemmer WPC, Kaptein R, Schatz PJ: Affinity selective isolation of ligands from peptide libraries through display on a lac repressor 'headpiece dimer'. J Mol Biol 1996, 255:373-386. Description of a monovalent, affinity-sensitive version of the lac repressor display method.
10. Mattheakis LC, Bhatt RR, Dower WJ: An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc Natl Acad Sci USA 1994, 91:9022-9026.
11. Gersuk GM, Corey MJ, Corey E, Stray JE, Kawasaki GH, Vessella RL: High-affinity peptide ligands to prostate antigen identified by polysome selection. Biochem Biophys Res Comm 1997 232:578-582.
12. Roberts RW, Szostak JW: RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci USA 1997 94:12297-12302.
13. Cunningham BC, Ultsch M, DeVos AM, Mulkerrin, MG, Clauser KR, Wells JA: Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 1991, 254:1330-1336.
14. DeVos AM, Ultsch M, Kossiakoff AA: Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992, 255:306-312.
15. Cunningham BC, Wells JA: Comparison of a structural and a functional epitope. J Mol Biol 1993, 234:554-563.
16. Clackson T, Wells JA: A hot spot of binding energy in a hormone-receptor interface. Science 1995, 267:383-386.
17. Wells JA: Binding in the growth hormone receptor complex. Proc Natl Acad Sci USA 1996, 93:1-6.
18. Yayon A, Avieser D, Safran M, Gross JL, Heldman Y, Cabilly S, Givol D, Katchalski-Katzir E: Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. Proc Natl Acad Sci USA 1993 90:10643-10647.
19. Li B, Tom JYK, Oare D, Yen R, Fairbrother WJ, Wells JA, Cunningham BC: Minimization of a polypeptide hormone. Science 1995 270:1657-1660.
20. LeSauteur L, Wei L, Gibbs B, Saragovi HU: Small peptide mimics of growth factor bind TrkA receptors and affect biological responses. J Biol Chem 1995 270:6564-6569.
21. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 1991, 77:1627-1652.
22. Yanofsky SD, Baldwin DN, Butler JH, Holden FR, Jacobs JW, Balasubramanian P, Chinn JP, Cwirla SE, Peters-Bhatt E, Whitehorn EA et al.: High affinity type I Interleukin-1 receptor antagonists discovered by screening recombinant peptide libraries. Proc Natl Acad Sci USA 1996, 93:7381-7366. This is the first reported example of a potent small peptide antagonist of a cytokine receptor. The paper serves as a good illustration of the process of discovery and affinity maturation of a peptide ligand.
23. Whitehorn EA, Tate E, Yanofsky SD, Kochersperger L, Davis A, Mortensen RB, Yonkovich S, Bell K, Dower WJ, Barrett RW: A generic method for expression and use of 'tagged' soluble versions of cell surface receptors. Nat Biotechnol 1995, 13:1215-1219.
24. Barrell RW, Cwirla SE, Ackerman MS, Olson AM, Peters EA, Dower WJ: Selective enrichment and characterization of high affinity ligands from collections of random peptides on filamentous phage. Anal Biochem 1992, 204:357-354.
25. Greenleder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G: Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J Biol Chem 1995, 270:13757-13765.
26. Ackeson AL, Woods CW, Hsieh LC, Bohnke RA, Ackermann BL, Chan KY, Robinson JL, Yanofsky SD, Jacobs JW, Barrett RW, Bowlin TL: AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J Biol Chem 1996, 271:30517-30523. This paper describes additional modifications of the interleukin-1 receptor ligands to improve antagonist activities.
27. Krantz SB: Erythropoietin: structure, control of production, and function. Blood 1991, 77:419-434.
28. Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jollifle LK, Dower WJ: Small peptides as potent mimetics of the protein hormone erythropoietin. Science 1996, 273:458-463. This paper reports the remarkable discovery of peptide ligands of the erythropoietin receptor that mimic the agonist activity of the protein growth factor erythropoietin.
29. Livnah O, Stura EA, Johnson DL, Middleton SA, Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe LK, Wilson IA: Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 Å. Science 1996, 273:464-471. This is a structural analysis of the erythropoietin mimetic peptides bound to the erythropoietin receptor. This also describes a 2:2 symmetrical dimer assembled by a dense network of peptide-peptide and peptide-receptor contacts.
30. Johnson DL, Farrell FX, Barbone FP, McMahon FJ, Tullai J, Hoey K, Livnah O, Wrighton NC, Middlelon SA, Loughney DA et al.: Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry 1998, 37:3699-3710.
31. Wrighlon NC, Balasubramanian P, Barbone FP, Kashyap AK, Farrell FX, Jolliffe LK, Barrett RW, Dower WJ: Increased potency of an erythropoietin peptide mimetic through covalent dimerization. Nat Biotechnol 1997, 15:1261-1265. This describes the effects of different peptide dimerization strategies on the in vitro and in vivo activities of the erythropoietin mimielic peptides.
32. Johnson DL, Farrell FX, Barbone FR McMahon FJ, Tullai J, Kroon D, Freedy J, Zivin RA, Mulcahy LS, Jolliffe LK: Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity. Chem Biol 1997 4:939-950. This describes the effects of different peptide dimerization strategies on the in vitro and in vivo activities of the eryhtropoietin mimetic peptides.
33. Kaushansky K: Thrombopoietin: the primary regulator of platelet production. Blood 1995, 86:419-431.
34. Cwirla SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, Davis AM, Tansik RL, Mattheakis LC, Boytos CM et al.: Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science 1997, 276:1696-1699. The report of a second example of peptides selected from random libraries that ara agonists of a growth factor receptor. This paper describes peptides that activate the thrombopoietin receptor with potency equivalent to the natural growth factor thrombopoietin.
35. Kimura T, Kaburaki H, Miyamoto S, Katayama J, Walanabe Y: Discovery of a novel thrombopoietin mimic agonist peptide. J Biochem 1997, 122:1046-1051.